Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 31;121(8):1240-1253.
doi: 10.1093/cvr/cvaf069.

Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration

Timothy J Aballo  1   2 , Jiyoung Bae  3 , Wyatt G Paltzer  1 , Emily A Chapman  4 , Andrew J Perciaccante  4 , Melissa R Pergande  1 , Rebecca J Salamon  1 , Dakota J Nuttall  1 , Morgan W Mann  5 , Ying Ge  1   4   6 , Ahmed I Mahmoud  1
Affiliations

Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration

Timothy J Aballo et al. Cardiovasc Res. .

Abstract

Aims: Adult mammalian cardiomyocytes (CMs) have limited regenerative potential, and after myocardial infarction (MI), injured cardiac tissue is replaced with fibrotic scar. In contrast, the neonatal mouse heart possesses a regenerative capacity governed by CM proliferation; however, a metabolic switch from glycolysis to fatty acid oxidation during post-natal development results in loss of this regenerative capacity. Interestingly, a sarcomere isoform switch also takes place during post-natal development where slow skeletal troponin I (ssTnI) is replaced with cardiac troponin I (cTnI). It remains unclear whether there is an interplay between sarcomere isoform switching, cardiac metabolism, and regeneration.

Methods and results: In this study, we employ proteomics, metabolomics, and lipidomics, transgenic mice, MI models, and histological analysis to delineate the molecular and sarcomeric transitions that occur during cardiac maturation and regeneration. First, we utilize integrated quantitative bottom-up and top-down proteomics to comprehensively define the proteomic and sarcomeric landscape during post-natal heart maturation. By employing a CM-specific ssTnI transgenic mouse model, we discovered that ssTnI overexpression increased CM proliferation and the cardiac regenerative capacity of the post-natal heart following MI compared to control mice by histological analysis. Our global proteomic analysis of ssTnI transgenic mice following MI reveals that ssTnI overexpression induces a significant shift in the cardiac proteomic landscape. Additionally, our lipidomic analysis demonstrated a significant up-regulation of lipid species in the transgenic mice. This proteomic shift is characterized by an up-regulation of key proteins involved in glycolytic metabolism.

Conclusion: Collectively, our data suggest that the post-natal TnI isoform switch may play a role in the metabolic shift from glycolysis to fatty acid oxidation during post-natal maturation. This underscores the significance of a sarcomere-metabolism axis during CM proliferation and heart regeneration.

Keywords: Cardiomyocyte proliferation; Heart regeneration; Lipidomics; Mass spectrometry; Metabolism; Metabolomics; Proteomics.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Y.G. is a co-inventor on a patent that covers the detergent Azo. Other authors declare no competing interests.

Update of

Comment in

References

    1. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge M-P, Thacker EL, Virani SS, Voeks JH, Wang N-Y, Wong ND, Wong SS, Yaffe K, Martin SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation 2023;147:e93–e621. - PMC - PubMed
    1. Murphy SP, Ibrahim NE, Januzzi JL Jr. Heart failure with reduced ejection fraction: a review. JAMA 2020;324:488–504. - PubMed
    1. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science 2011;331:1078–1080. - PMC - PubMed
    1. Mahmoud AI, Porrello ER, Kimura W, Olson EN, Sadek HA. Surgical models for cardiac regeneration in neonatal mice. Nat Protoc 2014;9:305–311. - PMC - PubMed
    1. Siedner S, Krüger M, Schroeter M, Metzler D, Roell W, Fleischmann BK, Hescheler J, Pfitzer G, Stehle R. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol 2003;548:493–505. - PMC - PubMed

MeSH terms